Nimbus Discovery, LLC: Series A $1.5M

Posted in I - Series A, Q - 1Q11, R - NORTH EAST, X - Computational Discovery, X - Metabolism, X - Oncology, XX - MA

Nimbus Discovery (Cambridge, MA) a development-stage biopharmaceutical focused on computational technologies to identify lead candidates for diffuse B-cell lymphoma and metabolic disease, closed a $1.5M Series A bringing the total financing to $5M. Participants include the Bill and Melinda Gates Foundation and Atlas Venture.

Feb

2010

Forma Therapeutics, Inc.: Series B $25.5M

Posted in I - Series B, Q - 4Q09, R - NORTH EAST, X - Computational Discovery, X - Device (HTS), XX - MA

Forma Therapeutics (Cambridge, MA) a development-stage screening and discovery company focused on cancer therapies, closed a $25.5M Series B financing. Participants include Lilly Ventures, Novartis Option Fund and Bio*One Capital.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Feb

2010

Therasis, Inc.: Series A $12M

Posted in I - Series A, Q - 4Q09, R - NORTH EAST, X - Computational Discovery, X - Device (HTS), XX - NY

Therasis (New York, NY) a development-stage computational systems biology cancer HTS drug discovery platform, closed a $12M Series A financing. Participants include Tilocor Life Science.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

to top of page...